AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limitedverified

ASTRAZEN.BO

Price:

$9211.5

Market Cap:

$230.66B

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-07-10

Stock Exchange

BSE

Ticker

ASTRAZEN.BO

The ROE as of December 2025 (TTM) for AstraZeneca Pharma India Limited (ASTRAZEN.BO) is 26.39%

According to AstraZeneca Pharma India Limited’s latest financial reports and current stock price. The company's current ROE is 26.39%. This represents a change of 303.82% compared to the average of 6.53% of the last 4 quarters.

AstraZeneca Pharma India Limited (ASTRAZEN.BO) Historical ROE (quarterly & annually)

How has ASTRAZEN.BO ROE performed in the past?

The mean historical ROE of AstraZeneca Pharma India Limited over the last ten years is 14.79%. The current 26.39% ROE has changed 78.46% with respect to the historical average. Over the past ten years (40 quarters), ASTRAZEN.BO's ROE was at its highest in in the September 2017 quarter at 12.68%. The ROE was at its lowest in in the December 2017 quarter at -4.79%.

Quarterly (TTM)
Annual

Average

14.79%

Median

15.95%

Minimum

3.37%

Maximum

22.69%

AstraZeneca Pharma India Limited (ASTRAZEN.BO) ROE by Quarter and Year

Discovering the peaks and valleys of AstraZeneca Pharma India Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 166.89%

Maximum Annual ROE = 22.69%

Minimum Annual Increase = -124.38%

Minimum Annual ROE = 3.37%

Quarterly (TTM)
Annual
YearROEChange
202515.02%-33.77%
202422.69%34.51%
202316.87%40.02%
202212.05%-41.11%
202120.45%3.22%
202019.81%9.46%
201918.10%72.51%
201810.49%16.64%
20179.00%166.89%
20163.37%-124.38%

AstraZeneca Pharma India Limited (ASTRAZEN.BO) Average ROE

How has ASTRAZEN.BO ROE performed in the past?

The current ROE of AstraZeneca Pharma India Limited (ASTRAZEN.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

18.19%

5-year avg

17.42%

10-year avg

14.79%

AstraZeneca Pharma India Limited (ASTRAZEN.BO) ROE vs. Peers

How is ASTRAZEN.BO’s ROE compared to its peers?

AstraZeneca Pharma India Limited’s ROE is less than Neuland Laboratories Limited (15.84%), less than Neuland Laboratories Limited (15.84%), less than Piramal Enterprises Limited (2.15%), greater than Piramal Pharma Limited (-0.29%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than Eris Lifesciences Limited (13.41%), less than Eris Lifesciences Limited (13.41%), greater than Wockhardt Limited (-0.53%), greater than Wockhardt Limited (-0.53%),

Build a custom stock screener for AstraZeneca Pharma India Limited (ASTRAZEN.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca Pharma India Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca Pharma India Limited (ASTRAZEN.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca Pharma India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is AstraZeneca Pharma India Limited's ROE?

How is the ROE calculated for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the highest ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the 3-year average ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

What is the 5-year average ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO)?

How does the current ROE for AstraZeneca Pharma India Limited (ASTRAZEN.BO) compare to its historical average?